Loading...
Docoh
Log in Free sign up

Bull Horn (BHSE)

News

From Benzinga Pro
Bull Horn Holdings Corp. Combination Partner Coeptis Therapeutics Enters Into Exclusive Option Agreement With University Of Pittsburgh For Rights To CAR-T Technologies Designed To Target Multiple Cancer Indications, Including Hematologic And Solid Tumors
17 May 22
Biotech, General
Option agreement comprises three technologies and associated patent portfolios Announcement marks the third strategic agreement for Coeptis this quarter designed to bolster its portfolio and complement its innovative
Cancer-Focused Coeptis Therapeutics Turns To SPAC Deal To Uplist To NASDAQ
20 Apr 22
Biotech, News, Penny Stocks, Health Care, Financing, Offerings, IPOs, General
Stocks That Hit 52-Week Highs On Thursday
7 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Thursday, 75 stocks made new 52-week highs.

Press releases

From Benzinga Pro
Coeptis Therapeutics Enters into Exclusive Option Agreement with University of Pittsburgh for Rights to CAR-T Technologies Designed to Target Multiple Cancer Indications, Including Hematologic and Solid Tumors
17 May 22
Press Releases
Option agreement comprises three technologies and associated patent portfolios Announcement marks the third strategic agreement for Coeptis this quarter designed to bolster its portfolio and complement its innovative
LEGENDARY GLOBAL FOOTBALL STAR RONALDINHO JOINS EXPANSION TEAM OWNERSHIP GROUP IN MAJOR ARENA SOCCER LEAGUE
6 May 22
Entertainment, Press Releases, General
NEW YORK, May 6, 2022 /PRNewswire/ -- Major Arena Soccer League today announced that Brazilian global football legend Ronaldo de Assis Moreira, affectionately known as Ronaldinho Gaúcho or simply Ronaldinho, is joining
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ACC, CMPI, BHSE
19 Apr 22
Press Releases
NEW YORK, April 19, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement
19 Apr 22
Small Cap, Press Releases
Transaction expected to accelerate Coeptis' ability to progress its innovative cell therapy platforms for cancer David Mehalick of Coeptis to serve as Chief Executive Officer; Chris Calise of Bull Horn to join the